Question special

As Eric Lander elegantly outlines in his Perspective piece, the regulatory frame surrounding genomic testing will need to change in this era of precision medicine (Lander, E.S., NEJM. 2015. PMID: 25689017). Current genetic tests often do not meet rigorous analytical and clinical standards, compromising their accuracy and utility. How can we better regulate genetic testing to ensure their analytical and clinical validity, while allowing these tests to come to market in a timely manner? What will this regulatory framework look like?